Canada Markets open in 1 hr 56 mins

Protagenic Therapeutics, Inc. (PTIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0800+0.0100 (+0.93%)
At close: 04:00PM EST
1.0800 0.00 (0.00%)
After hours: 07:57PM EST
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) -0.45
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.8900
52 Week Low 30.9100
50-Day Moving Average 31.5760
200-Day Moving Average 32.0668

Share Statistics

Avg Vol (3 month) 3242.07k
Avg Vol (10 day) 3158.61k
Shares Outstanding 516.96M
Implied Shares Outstanding 6N/A
Float 811.69M
% Held by Insiders 123.32%
% Held by Institutions 15.71%
Shares Short (Dec. 14, 2021) 4157.05k
Short Ratio (Dec. 14, 2021) 40.79
Short % of Float (Dec. 14, 2021) 41.16%
Short % of Shares Outstanding (Dec. 14, 2021) 40.93%
Shares Short (prior month Nov. 14, 2021) 4112.55k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul. 26, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:15464
Last Split Date 3Jul. 26, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.68%
Return on Equity (ttm)-88.90%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-4.16M
Diluted EPS (ttm)-0.3180
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.85M
Total Cash Per Share (mrq)0.64
Total Debt (mrq)562.09k
Total Debt/Equity (mrq)5.42
Current Ratio (mrq)16.09
Book Value Per Share (mrq)0.61

Cash Flow Statement

Operating Cash Flow (ttm)-2.71M
Levered Free Cash Flow (ttm)-1.35M